AlphaGrep UK
CAH icon

AlphaGrep UK’s Cardinal Health CAH Stock Holding History

AlphaGrep UK’s Portfolio CAH Stock Details CAH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$873K Buy
3,925
+940
+31% +$219K 0.26% 58
2026
Q2 		$709K Sell
2,985
-4,664
-61% -$969K 0.21% 114
2026
Q1 		$1.62M Buy
7,649
+1,291
+20% +$278K 0.47% 8
2025
Q4 		$1.31M Buy
+6,358
New +$1.2M 0.44% 12

Other funds holding CAH

BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.96T AUM 27.49% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.27T AUM 50.62% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.84T AUM 33.86% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $59.1B AUM 41.96% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $179B AUM 29.92% 1-Year Est. Return

AlphaGrep UK's CAH Position: Q3 2026 in Review

AlphaGrep UK increased its Cardinal Health (CAH) stake by 31% in Q3 2026, buying an estimated $219K and bringing the position to 3,925 shares worth $873K. The position accounts for 0.26% of the portfolio, ranked #58.

AlphaGrep UK first reported a position in CAH in Q4 2025 and has held it in 4 quarters since. The position peaked at $1.62M in Q1 2026. 1,272 funds tracked by Wall St. Rank hold CAH as of Q3 2026.

  • AlphaGrep UK held 3,925 shares of Cardinal Health worth $873K as of Q3 2026.
  • AlphaGrep UK bought 940 Cardinal Health shares in Q3 2026, an estimated $219K.
  • Cardinal Health made up 0.26% of AlphaGrep UK's portfolio in Q3 2026, its #58 holding.
  • AlphaGrep UK first reported a position in Cardinal Health in Q4 2025 and has held it in 4 quarters since.
  • AlphaGrep UK's Cardinal Health position peaked at $1.62M in Q1 2026.
  • 1,272 funds tracked by Wall St. Rank held Cardinal Health as of Q3 2026.

Based on AlphaGrep UK's 13F filing for Q3 2026, filed 12 Nov 2026.